Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

V Sibaud1, D Guerrero2, V Georgescu3

  • 1Départements d'Oncologie Médicale et Oncodermatologie, Institut Universitaire du Cancer Toulouse - Oncopole, 1 avenue Irène Joliot-Curie, 31059 Toulouse Cedex 9, France.

Annales De Dermatologie Et De Venereologie
|January 28, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Gamma secretase inhibitor nirogacestat and secondary hidradenitis suppurativa: An expected on-target effect.

Annales de dermatologie et de venereologie·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Cancer treatments often cause skin toxicities, impacting patients

Area of Science:

  • Oncology
  • Dermatology
  • Supportive Care

Background:

  • Cancer treatments, particularly cytotoxic chemotherapy (e.g., taxanes), frequently induce dermatological toxicities affecting skin, nails, and hair.
  • These adverse events can significantly impair patients' quality of life (QoL), causing physical, social, and psychological distress.
  • Dermatological side effects may persist post-treatment, necessitating effective supportive care strategies.

Purpose of the Study:

  • To evaluate the role of hydrotherapy in managing cancer-related dermatological toxicities.
  • To assess the impact of hydrotherapy on the quality of life, specifically dermatological quality of life, in breast cancer patients.
  • To clarify the potential benefits of hydrotherapy as a supportive care measure for managing treatment-induced skin issues.

Main Methods:

Keywords:
ChemotherapyChimiothérapieDermatologic adverse eventsEffets indésirables dermatologiquesHydrotherapyOncodermatologieOncodermatologyThermalToxicityToxicité

Related Experiment Videos

  • Review of existing data on hydrotherapy interventions for patients undergoing cancer treatment.
  • Focus on studies involving breast cancer patients who received hydrotherapy.
  • Analysis of patient-reported outcomes related to quality of life and dermatological health.

Main Results:

  • Dermatological toxicities are a common and burdensome side effect of cancer therapies.
  • Hydrotherapy has been proposed as a supportive care measure, but its efficacy requires further investigation.
  • Data on the specific impact of hydrotherapy on dermatological quality of life in breast cancer survivors is summarized.

Conclusions:

  • There is a significant need for supportive care to manage persistent dermatological toxicities from cancer treatments.
  • The precise role and effectiveness of hydrotherapy in improving dermatological quality of life for cancer patients remain to be fully elucidated.
  • Further research is warranted to establish hydrotherapy's place in supportive care protocols for managing cancer-related skin conditions.